Drug insight: an overview of current anticoagulation therapy after heart valve replacement.

about

Endothelial retention and phenotype on carbonized cardiovascular implant surfaces.Managing mechanical valves with reduced anticoagulation.Pharmacodynamics of uniform versus nonuniform warfarin dosages.Craniotomy with prosthetic heart valves: a clinical dilemma.

P2860

Q35642221-51E66677-F634-4E1D-B1B2-5E1E772A0440 Q37012926-0806716C-3FA7-4823-9A2D-568FF2BD54AB Q46575263-46E34367-70FD-4CA3-BDF4-A4C55E8CF17F Q48540864-75976B64-C7B4-431C-8F10-4C74658945D8

P2860

Drug insight: an overview of current anticoagulation therapy after heart valve replacement.

Item

http://www.wikidata.org/entity/Q36239522

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Drug insight: an overview of c ...... after heart valve replacement.

@ast

Drug insight: an overview of c ...... after heart valve replacement.

@en

type

Item

label

Drug insight: an overview of c ...... after heart valve replacement.

@ast

Drug insight: an overview of c ...... after heart valve replacement.

@en

prefLabel

Drug insight: an overview of c ...... after heart valve replacement.

@ast

Drug insight: an overview of c ...... after heart valve replacement.

@en

P1476

Drug insight: an overview of c ...... after heart valve replacement.

@en

P2093

Cornelia Piper

http://www.w3.org/2001/XMLSchema#string

Detlef Hering

http://www.w3.org/2001/XMLSchema#string

Dieter Horstkotte

http://www.w3.org/2001/XMLSchema#string

P2860

Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Warfarin, aspirin, or both after myocardial infarction

Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?

Clinical uses of low-molecular-weight heparins.

Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.

Comparative pharmacokinetics of LMWHs.

Anticoagulation of pregnant women with mechanical heart valves.

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

P304

415-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPCARDIO0271

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16119704

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Drug insight: an overview of current anticoagulation therapy after heart valve replacement.

about

P2860

P2860

Drug insight: an overview of current anticoagulation therapy after heart valve replacement.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921